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Autonomic failureMultiple system atrophy (MSA) is a fatal, rapidly progressive neurodegenerative disease with limited symp-
tomatic treatment options. Discrimination of MSA from other degenerative disorders crucially depends on
the presence of early and severe cardiovascular autonomic failure (CAF). We have previously shown that
neuropathologic lesions in the central autonomic nuclei similar to the human disease are present in transgenic
MSA mice generated by targeted oligodendroglial overexpression of α-syn using the PLP promoter. We here
explore whether such lesions result in abnormalities of heart rate variability (HRV) and circadian rhythmicity
which are typically impaired in MSA patients.
HRV analysis was performed in ﬁve month old transgenic PLP-α-syn (tg) MSA mice and age-matched wild
type controls. Decreased HRV and alterations in the circadian rhythmicity were detected in the tg MSA
group. The number of choline-acetyltransferase-immunoreactive neurons in the nucleus ambiguus was
signiﬁcantly decreased in the tg group, whereas the levels of arginine-vasopressin neurons in the
suprachiasmatic and paraventricular nucleus were not affected. Our ﬁnding of impaired HRV and circadian
rhythmicity in tg MSA mice associated with degeneration of the nucleus ambiguus suggests that a cardinal
non-motor feature of human MSA can be reproduced in the mouse model strengthening its role as a valuable
testbed for studying selective vulnerability and assessing translational therapies.
© 2013 Elsevier Inc. Open access under CC BY-NC-ND license. Introduction
Multiple system atrophy (MSA) is a rapidly progressive neurode-
generative disease with unclear etiology. The disease can be classiﬁed
into 2 motor subtypes: a parkinsonian variant (MSA-P) that accounts
for 80% of cases in the western world and is caused by striatonigralSA, multiple system atrophy;
variant of MSA; α-syn, alpha-
livopontocerebellar atrophy;
, sporadic adult onset ataxia;
e; wt, wild type; tg, transgenic;




ck, Austria. Fax: +43 512/504
enning).
sitätklinikum Münster, Albert-
NC-ND license. degeneration (SND) and the cerebellar subtype (MSA-C) that results
from olivopontocerebellar atrophy (OPCA) and is the predominant
MSA subtype in Asia (Wenning and Stefanova, 2009). Besides the
motor symptoms progressive autonomic failure is an important
feature of MSA that is obligatory for the diagnosis (Gilman et al.,
2008; Jecmenica-Lukic et al., 2012). The spectrum of autonomic
failure in MSA includes disturbances of the cardiovascular system
(e.g. orthostatic hypotension, and diminished heart rate variability),
impaired respiratory function, urinary and erectile dysfunction,
sudomotor disturbances (anhidrosis) or circadian rhythm disturbances
mostly resulting from degeneration of the neuronal networks in the
brainstem and preganglionic efferent autonomic systems (Benarroch,
2002, 2003; Ozawa, 2007).
Heart rate variability (HRV) is a physiological phenomenon that
describes the variation of the distance (time) between consecutive
R waves (R-R Interval) in an ECG signal and reﬂects the balance
between the sympathetic and parasympathetic systems (Malliani et
al., 1991). HRV reduction has been associated with various disorders
(Agelink et al., 2002; Bleil et al., 2008; Lavoie et al., 2004; Malpas
and Maling, 1990; Martens et al., 2008). Several studies have been
performed inMSApatients to investigate cardiac autonomic dysfunction
describing HRV as a potential biomarker for distinguishing MSA from
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ataxias (SAOAs) (Abele et al., 2004; Diedrich et al., 2002; Furushima
et al., 2012; Kitae et al., 2001; Kiyono et al., 2012; Toshihide et al.,
2006). A recent study by Nishizawa and co-workers evaluated time-
domain and frequency-spectrum measures of HRV in 14 MSA-C and 3
MSA-P patients and detected that all HRV parameters (RMSSD — root
mean square of successive RR interval differences, HF — high
frequency and LF — low frequency) except LF/HF ratio were decreased
in MSA patients compared to healthy controls (Furushima et al.,
2012). Importantly, inverse correlations between HRV and disease pro-
gression were shown in MSA patients (Furushima et al., 2012; Kitae et
al., 2001). Decreased HRV and disturbed circadian rhythm were
reported inMSAand PDpatients compared to early-onset parkinsonism
patients and healthy controls, with MSA showing more pronounced
changes than PD (Kiyono et al., 2012; Toshihide et al., 2006).
The neuropathological correlate of CAF in MSA has been linked to
a distributed degeneration of multiple autonomic areas including
preganglionic sympathetic neurons in the intermediolateral cell col-
umn, cholinergic neurons in the nucleus ambiguus and dorsal motor
nucleus of the vagus, as well as arginine-vasopressin neurons in the
suprachiasmatic and paraventricular nucleus and TH neurons in the
ventrolateral medulla and periventricular area (Benarroch, 2002, 2003;
Benarroch et al., 2002, 2003, 2006a, 2006b; Ozawa, 2007; Scheer et al.,
2003; Singewald and Philippu, 1996; Tsai et al., 1992). It is presently
considered that MSA is a primary oligodendrogliopathy characterized
by the presence of α-synuclein (α-syn)-positive (oligodendro-)glial
cytoplasmic inclusions (GCIs)which play amajor role inMSApathogen-
esis (Gilman et al., 2008;Wenning et al., 2008). However, the exact role
of α-syn with regard to autonomic regulation and cardiovascular
dysfunction in MSA is still unclear.
Transgenic (tg) MSA mice with speciﬁc oligodendroglial expression
of human α-syn (hα-syn) under the control of the proteolipid protein
(PLP) promoter (Kahle et al., 2002) have proven useful to study MSA-
related pathogenic mechanisms (Stefanova et al., 2005, 2007, 2011,
2012). The tg MSAmouse model features GCIs as well as mild, progres-
sive SND and OPCA, microgliosis and motor impairment (Kahle et al.,
2002; Stefanova et al., 2005; Stemberger et al., 2010). Analysis of
regions associated with autonomic functions revealed neuronal loss in
the Onuf's nucleus and progressive degeneration of cholinergic neurons
in the nucleus ambiguus, laterodorsal tegmental nucleus and
pedunculopontine tegmental nucleus (Stemberger et al., 2010). These
primary neuropathological ﬁndings gave reason to speculate about
possible autonomic failure in this tgMSAmodel and served as the ratio-
nale for this study. Therefore, in the current study we assessed the
cardiovascular phenotype of adult MSA mice by analyzing HRV and
circadian rhythm as well as central autonomic neuropathology related
to α-syn overexpression.Materials and methods
Animal groups and implantation of radio-telemetry transmitters
Five month old, male, transgenic mice expressing hα-syn under
the control of the oligodendroglial proteolipid protein (PLP) promoter
in C57BL/6-background [previously described (Kahle et al., 2002;
Stefanova et al., 2005)] and age-matched C57BL/6 mice as wild type
(wt) control group were individually housed 24 h before the onset of
the surgery and for the duration of the whole behavioral testing.
All mice were anesthetized with isoﬂurane (1.5–2%) and implanted
with TA10ETAF10 transmitters (Data Sciences International, USA) as
previously described (Gaburro et al., 2011; Stiedl and Spiess, 1997;
Stiedl et al., 1999). Post-surgically, all animals were treated with
buprenorphione, a semi-synthetic opioid (0.2 mg/kg i.p.) for three
days. Animals were further allowed to recover for 10 days before con-
duction of the behavioral tests.Locomotion and ECG data acquisition and analysis
Recordings of locomotor activity, heart rate, body temperature
and ECG were acquired by the use of TA10ETAF10 radio-telemetry
transmitters and the appropriate recording system. Animals were
kept in their home cage throughout the 48-h observation period.
Dataquest A.R.T. 4.1 software (Data Sciences International, St. Paul,
USA) was used for data collection. For ECG data editing, the ECG
signal was exported to Chart software (Chart 5.0, AD Instruments,
Germany) as a text ﬁle as previously described (Gaburro et al.,
2011). Data for locomotor activity, body temperature and heart rate
were averaged in 1-h intervals. Ten 30-s intervals were used per
animal to calculate the HRV (expressed in RMSSD) and to obtain values
for frequency-spectrum analysis (high frequency—HF, low frequency—
LF and the ration between LF and HF — LF/HF). The time-points for
basal HRV were chosen between 09:00 and 13:00 for the light-phase
and between 21:00 and 03:00 for the dark phase when basal HR levels
should be highest (Li et al., 1999).Histological analysis
After the behavioral recordings were completed, animals were
perfused under deep thiopental anesthesia with 5 ml of phosphate
buffered saline followed by 40 ml of ice-cold 4% paraformaldehyde
(PFA) (pH 7.4) (Sigma). Brains were removed and post-ﬁxed in 4%
PFA over night at 4 °C. Afterwards, they were put in 30% sucrose
until they sank, before they were frozen with 2-methylbutane and
kept at −80 °C until processing. The brains were sliced in three
series of coronal, adjacent 40-μm sections on a freezing microtome
(Leica, Nussloch, Germany) and stored free-ﬂoating in a cryoprotective
solution at −20 °C. The following antibodies were used in this study:
polyclonal goat-anti-ChAT (1:3000, Chemicon, Temecula, CA), polyclonal
rabbit-anti-AVP (1:500, Novus biological, Littleton, CO), secondary anti-
bodies were biotinylated horse anti-goat IgG and biotinylated goat
anti-rabbit IgG (Vector Laboratories, Burlingame or, CA). All quantiﬁca-
tion analysis was done by a blinded observer using the optical disector
method (Nikon Eclipse E800 microscope, Nikon camera DXM1200
Stereo Investigator Software, Micro Bright Field Europe, Magdeburg,
Germany).Statistical analysis
Statistical analysis was performed using GraphPad Prism 5.3 and
Statistica 8.0 (StatSoft, USA) Software. Analysis of variance (ANOVA)
was performedwith factor linewt and tg groups and repeatedmeasures
for time (day versus night) as the second factor for activity, body
temperature and heart rate analysis. Two-way ANOVA was performed
for analysis of the HRV using RMSSD and frequency-spectrum analysis
(HF, LF, LF/HF). Data plotted in graphs are means±S.E.M. Post-hoc
Bonferroni t-test was applied where it is appropriate. *=pb0.05;
**=pb0.01; ***=pb0.001.Results
Circadian changes in locomotor activity, heart rate and core body
temperature
During the 48 h recording period, different patterns of spontaneous
locomotor activity, heart rate and temperature were detected in ﬁve
month old tg MSA mice as compared to age-matched wt controls.
Repeated measures ANOVA revealed signiﬁcantly lower values in the
tg group during night regarding activity (F48, 768=2.3278, pb0.0001;
Fig. 1A), heart rate (F48, 768=3.2192, pb0.0001; Fig. 1B) and core
body temperature (F48, 768=5.5873, pb0.0001; Fig. 1C).
Fig. 1. Assessment of circadian rhythm parameters: ﬁve month old wt (white) and tg MSA (gray) animals show differences in day–night-rhythm in their home cage regarding
A) locomotor activity [expressed as counts per minute (counts/min)], B) HR [expressed as beats per minute (BPM)] and C) temperature [°C]. Especially regarding the activity levels,
tg MSA animals do not show the characteristic day–night-ﬂuctuations e.g. their circadian rhythm is blunted and clearly differs from wt animals. Black bars indicate active night
periods, and white bars indicate day phases. Data plotted are means±S.E.M., n(tg)=9, n(wt)=6 animals.
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HRV measured in the time domain analysis (RMSSD) was signiﬁ-
cantly reduced in tg MSA animals as compared to control animals
both during light and dark phases (F1, 635=26.956, pb0.0001;
Fig. 2). Accordingly, the respective frequency domain values HF and
LF were reduced in tg MSA animals as compared to controls during
day and night phases (HF: F1, 635=140.00, pb0. 001 (Fig. 3A); LF:
F1, 635=92.29, day: pb0.001, night: pb0.05 (Fig. 3B)). Lower HF
and LF values were observed during light as compared to darkFig. 2. Time-domain analysis of HRV (plotted as RMSSD [ms] — root mean square of
successive RR interval differences) of ﬁve month old, male, wt and tg MSA animals. HRV
is signiﬁcantly decreased in transgenic animals at day and night. Data are means±
S.E.M. n(tg)=9, n(wt)=7 animals.phase in the tg MSA group only (HF: F1, 635=18.71, tg: pb0.001
(Fig. 3A); LF: F1, 635=19.33, tg: pb0.001 (Fig. 3B)). The LF/HF ratio
was signiﬁcantly higher in tg MSA animals compared to the wt group
during day phases (F1, 635=15.38, pb0.001; Fig. 3C). In the wt group
there was further signiﬁcant increase of the LF/HF ratio in the dark
versus light phase (F1, 635=4.178, pb0.01).
Immunohistochemical analysis of neurodegeneration
Quantiﬁcation of ChAT-immunoreactive neurons in the nucleus
ambiguus revealed a signiﬁcant reduction in tg MSA animals (Figs. 4
and 5). However, the number of AVP-immunoreactive neurons in
two further regions associated with cardiovascular regulation – the
suprachiasmatic nucleus and the paraventricular nucleus – was not
altered in tg MSA animals (Figs. 4 and 6).
Discussion
This study aimed to analyze cardiac autonomic function in the
well established PLP-tg mouse model of MSA (Kahle et al., 2002;
Stefanova et al., 2005; Stemberger et al., 2010). Detailed characteriza-
tion of animal models is of great importance to determine how closely
they replicate the human disease pathology and deﬁne their rele-
vance for investigating pathological disease mechanisms and testing
potential therapeutical approaches. Detection of possible cardiovascu-
lar impairment as present in human MSA patients (Furushima et al.,
2012; Kitae et al., 2001; Pagani et al., 1997; Wenning et al., 2008)
and reﬂection of the previously reported degeneration of the central
autonomic areas in the PLP-tg MSA mouse model were the main focus
Fig. 3. Frequency-spectrum analysis of ﬁve month old, male, wt and tg MSA animals.
A) High frequency (HF) [ms2] representing vagal function, B) low frequency (LF) [ms2]
illustrating sympathovagal balance and C) LF/HF ratio representing sympathovagal
balance. Data are means±S.E.M. n(tg)=9, n(wt)=7 animals.
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of selective degeneration involving the nucleus ambiguus. For the
ﬁrst time, we now demonstrate impaired heart rate variability and
circadian rhythmicity as a functional read-out reﬂecting CAF and central
autonomic neuropathology in the tg MSA mouse model.
Circadian changes in locomotor activity, heart rate and core body
temperature
Home-cage circadian rhythmicity measured by assessing heart rate,
core body temperature and locomotor activity in wt mice analyzed in
this study were consistent with previously reported data (Gaburro et
al., 2011; Sanchez-Alavez et al., 2011). Circadian rhythmmeasurements
of tg animals differed from these patterns with reduced nocturnal
activity, heart rate and temperature. Impaired circadian ﬂuctuations as
observed here are consistent with the human disease (Moreno-Lopez
et al., 2011; Toshihide et al., 2006).
Impaired HRV in tg group
We observed reduced HRV in the tg MSAmice consistent with CAF
reﬂecting central autonomic pathology observed in the nucleus
ambiguus similar to human MSA (Abele et al., 2004; Diedrich et al.,2002; Furushima et al., 2012; Iodice et al., 2012; Kitae et al., 2001;
Kiyono et al., 2012; Mathias, 2006; Plaschke et al., 1998; Toshihide
et al., 2006). The reduced HRV was indicated by both time- and
frequency-domain levels in the tg animal model again similar to the
human disease (Furushima et al., 2012). The decrease of the HF com-
ponents of HRV spectral analysis in tg MSA mice reﬂects what has
been observed in MSA patients (Diedrich et al., 2002; Furushima et
al., 2012).
LF has been reported to be regulated by neural activities of sympa-
thetic components (Berger et al., 1989). As for human MSA patients
(Diedrich et al., 2002; Furushima et al., 2012), a signiﬁcant reduction
of LF was detected in the tg MSA mice throughout the day and night.
Furthermore, the ratio LF/HF reported to be higher in human MSA
cases (Furushima et al., 2012) was also found to be signiﬁcantly
increased in tg MSA animals during the day as compared to controls
indicating a dysregulation of sympathovagal balance (Diedrich et al.,
2002; Furushima et al., 2012). A high LF/HF ratio principally suggests
an increased sympathetic or decreased parasympathetic activity
(Malliani et al., 1991; Montano et al., 1994; Pagani et al., 1997). Based
on ﬁndings in MSA patients (Furushima et al., 2012; Kiyono et al.,
2012), we conclude that in the current study changes in HRV patterns
(HF, LF and ratio)may be also attributed to an impaired parasympathetic
activity whichmatches with the neuropathological ﬁndings of choliner-
gic neurodegeneration in the nucleus ambiguus in this animal model
and goes in line with reports from human MSA patients (Kiyono et al.,
2012).
Immunohistochemical analysis of neurodegeneration
MSA brains show neurodegeneration in areas associated with CAF
e.g. degeneration of the intermediolateral cell column, cholinergic
depletion in the nucleus ambiguus and dorsal motor nucleus of
the vagus, degeneration of arginine-vasopressin neurons in the
suprachiasmatic and paraventricular nucleus, and loss of TH neurons
in the ventrolateral medulla and periventricular area (Benarroch,
2002, 2003; Benarroch et al., 2002, 2003, 2006a, 2006b; Ozawa,
2007; Tsai et al., 1992). To further investigate whether cardiovascular
autonomic dysfunction (decreased HRV) reﬂects central autonomic
pathology in the tg MSA animal model, three of the brain regions
affected by human MSA were chosen as the main regions of interest
for this study: 1) the nucleus ambiguus associated with cardiovagal
function (Benarroch et al., 2003, 2006a, 2006b; Ozawa, 2007), 2) the
suprachiasmatic nucleus relevant for circadian rhythm and response
to stress (Benarroch et al., 2006a, 2006b; Ozawa, 2007) and 3) the
paraventricular nucleus involved in blood pressure maintenance, respi-
ration and responses to stress (Benarroch, 2002, 2003; Benarroch et al.,
2006a, 2006b; Ozawa, 2007). The functions of these areas are compara-
ble between humans and rodents and have been used for histological
analysis in HRV or circadian rhythm studies of other conditions
such as PD or Huntington's disease (Dai et al., 1998; Koutcherov et al.,
2000; Kudo et al., 2011a, 2011b; Rentero et al., 2002; Scheer et al.,
2003; Sheward et al., 2010; Tsai et al., 1992; Yan et al., 2009). The reduc-
tion of ChAT-immunoreactive neurons in the nucleus ambiguus of
the ﬁve month old tg MSA animals in this study, corroborates previous
ﬁndings in the same model showing a slight trend towards reduction
at 2 months and a marked decrease at 12 months of age. This loss of
cholinergic neurons in the nucleus ambiguus has also been reported
in human MSA patients and is associated with cardiovascular distur-
bances. The loss of AVP neurons described in the human disease
(Benarroch et al., 2002, 2006a, 2006b) is thought to mediate CAF but
could not be detected in the tg MSA model of this study.
Conclusion
This study was the ﬁrst to show decreased HRV and impaired
circadian rhythmicity in a tg animal model for MSA. The ﬁnding
Fig. 4. Illustration of immunohistochemical labelings. A) Localization of the nucleus ambiguus (NA) and C) the paraventricular nucleus (PVN) and suprachiasmatic nucleus (SCN) is
illustrated at selected Bregma levels. B) Choline-acetyltransferase (ChAT)-immunohistochemistry indicated loss of cholinergic neurons in the NA of tg animals. D) Representative
microphotographs showing arginine-vasopressin (AVP) immunohistochemical stainings in the PVN of wild type (wt) and transgenic (tg) animals. Bars, 90 μm.
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MSA underscores the translational value of this animal model.
How overexpression of hα-syn in oligodendrocytes leads to
neurodegeneration in areas of autonomic regulation and thereby
induces autonomic failure, is still unclear, however, our data indicate
that the presence ofα-syn aggregates is an essential key event in MSA
pathology linked to central cardiovascular autonomic failure.Acknowledgments
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